Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Fri Dec 15 16:18:17 GMT 2023
by
admin
on
Fri Dec 15 16:18:17 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | BACTERIUM |
| Source Materials State | KILLED |
| Source Materials Parent | |
| Author | (LEHMANN & NEWMANN) WINSLOW ET AL. |
| Infraspecific Type | STRAIN |
| Infraspecific Name | 20752 |
| Part Location | OUTER |
| Part | CAPSULE |
| Fraction Material Type | POLYSACCHARIDE |
| Fraction Name | POLYRIBOSYL-RIBITOL-PHOSPHATE POLYSACCHARIDE |
| Record UNII |
C9R35M8XV6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000183888
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB10990
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY | |||
|
N0000183364
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY | Actively Acquired Immunity [PE] | ||
|
N0000170916
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY | Vaccines, Inactivated [Chemical/Ingredient] | ||
|
N0000170883
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY | Haemophilus Vaccines [Chemical/Ingredient] | ||
|
C87740
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY | |||
|
C9R35M8XV6
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY | |||
|
C9R35M8XV6
Created by
admin on Fri Dec 15 16:18:17 GMT 2023 , Edited by admin on Fri Dec 15 16:18:17 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->VACCINE ANTIGEN |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | K3W1N8YP13 | ||||
| CONJUGATION | CONJUGATING AGENT |
|
ADIPIC ACID DIHYDRAZIDE | VK98I9YW5M |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| PROTEIN CONJUGATION |
Amount:
|
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | K3W1N8YP13 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:WEIGHT AVERAGE | CHEMICAL |
|
|
|||